CBD: The Cannabis Industry Game-Changer?

(Panel Discussion) It’s cannabis without the high, but with all the analgesic and anti-inflammatory properties. And it opens the business up to markets far beyond the already robust existing one. This session will offer insights into the exponential growth of the THC-free analgesic product throughout the Western world, in everything from pet supplements to human health products. Is CBD a true “disruptor” to the pharmaceutical industry and others? How do its regulations vary across jurisdictions? If medical-sounding claims are made, will that invite more regulation? And with countless brands and competitors, what will the eventual shakedown look like? You’ve got questions, we’ve got answers. Moderated By: Megan Henderson